Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation.

TitleTranscription factor IRF8 directs a silencing programme for TH17 cell differentiation.
Publication TypeJournal Article
Year of Publication2011
AuthorsOuyang X, Zhang R, Yang J, Li Q, Qin L, Zhu C, Liu J, Ning H, Shin MSun, Gupta M, Qi C-F, He JCijiang, Lira SA, Morse HC, Ozato K, Mayer L, Xiong H
JournalNat Commun
Volume2
Pagination314
Date Published2011
ISSN2041-1723
KeywordsAnimals, Cell Differentiation, Cell Lineage, Female, Gene Silencing, Interferon Regulatory Factors, Interleukin-17, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Sequence Deletion, Th17 Cells
Abstract

T(H)17 cells are recognized as a unique subset of T helper cells that have critical roles in the pathogenesis of autoimmunity and tissue inflammation. Although RORγt is necessary for the generation of T(H)17 cells, the molecular mechanisms underlying the functional diversity of T(H)17 cells are not fully understood. Here we show that a member of interferon regulatory factor (IRF) family of transcription factors, IRF8, has a critical role in silencing T(H)17-cell differentiation. Mice with a conventional knockout, as well as a T cell-specific deletion, of the Irf8 gene exhibited more efficient T(H)17 cells. Indeed, studies of an experimental model of colitis showed that IRF8 deficiency resulted in more severe inflammation with an enhanced T(H)17 phenotype. IRF8 was induced steadily and inhibited T(H)17-cell differentiation during T(H)17 lineage commitment at least in part through its physical interaction with RORγt. These findings define IRF8 as a novel intrinsic transcriptional inhibitor of T(H)17-cell differentiation.

DOI10.1038/ncomms1311
Alternate JournalNat Commun
PubMed ID21587231
Grant List / ImNIH / Intramural NIH HHS / United States
Related Faculty: 
Lihui Qin, M.D., Ph.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700